Your browser doesn't support javascript.
loading
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type.
Tarantelli, Chiara; Cannas, Eleonora; Ekeh, Hillarie; Moscatello, Carmelo; Gaudio, Eugenio; Cascione, Luciano; Napoli, Sara; Rech, Cesare; Testa, Andrea; Maniaci, Chiara; Rinaldi, Andrea; Zucca, Emanuele; Stathis, Anastasios; Ciulli, Alessio; Bertoni, Francesco.
Afiliação
  • Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Cannas E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Ekeh H; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Moscatello C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Gaudio E; Department of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, I-66100 Chieti, Italy.
  • Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Napoli S; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Rech C; SIB Swiss Institute of Bioinformatics, 1000 Lausanne, Switzerland.
  • Testa A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Maniaci C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Rinaldi A; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, Scotland, UK.
  • Zucca E; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, Scotland, UK.
  • Stathis A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Ciulli A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, 6500 Bellinzona, Switzerland.
  • Bertoni F; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.
Explor Target Antitumor Ther ; 2(6): 586-601, 2021.
Article em En | MEDLINE | ID: mdl-36046113

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Explor Target Antitumor Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Explor Target Antitumor Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça